The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer. [electronic resource]
Producer: 19960531Description: 6-12 p. digitalISSN:- 0007-1048
- Adult
- Cell Count -- drug effects
- Cell Movement -- drug effects
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology
- Hematopoietic Stem Cells -- drug effects
- Hodgkin Disease -- blood
- Humans
- Interleukin-3 -- pharmacology
- Leukocyte Count -- drug effects
- Lymphoma -- blood
- Lymphoma, Non-Hodgkin -- blood
- Male
- Middle Aged
- Ovarian Neoplasms -- blood
- Platelet Count -- drug effects
- Recombinant Fusion Proteins -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.